Can a med spa in Minnesota offer compounded semaglutide or tirzepatide?
Intake · part of The Practice Perimeter
⚠️ COMPOUNDED SEMAGLUTIDE IS PATIENT-SPECIFIC BY DEFINITION IN MINNESOTA. “Compounding” means preparing, mixing, assembling, packaging, and labeling a drug FOR AN IDENTIFIED INDIVIDUAL PATIENT AS A RESULT OF A PRACTITIONER’S PRESCRIPTION DRUG ORDER — and the definition closes with the general rule: “ALL COMPOUNDING, REGARDLESS OF THE TYPE OF PRODUCT, MUST BE DONE PURSUANT TO A PRESCRIPTION DRUG ORDER unless otherwise permitted in this chapter or by the rules of the board.” A med spa cannot lawfully stock generic compounded vials against future demand.
Minn. Stat. § 151.01, subd. 35 · verified Sep 2, 2026 · regulatory monitoring, not legal advice
The rest of what Minnesota says on this
Every other rule we have verified under good-faith examination, each linked to its primary source.
⚠️ THE RULE, AND IT VOIDS THE PRESCRIPTION RATHER THAN MERELY EXPOSING THE PRESCRIBER. “A prescription drug order for the following drugs IS NOT VALID, unless it can be established that the prescription drug order was based on A DOCUMENTED PATIENT EVALUATION, INCLUDING AN EXAMINATION, ADEQUATE TO ESTABLISH A DIAGNOSIS AND IDENTIFY UNDERLYING CONDITIONS AND CONTRAINDICATIONS TO TREATMENT.” The list is closed: controlled substances under § 152.02, board-defined controlled substances, MUSCLE RELAXANTS, centrally acting analgesics with opioid activity, drugs containing butalbital, and PDE5 inhibitors used to treat erectile dysfunction.
Minn. Stat. § 151.37, subd. 2(d) · verified Sep 2, 2026
⚠️ WHICH MED SPA SERVICES THIS ACTUALLY REACHES — the list is by DRUG CLASS, not by procedure. TESTOSTERONE IS A SCHEDULE III CONTROLLED SUBSTANCE, so a practice offering hormone or “optimization” therapy is inside the rule and its prescription is not valid without a documented examination. Botulinum toxin, dermal fillers and semaglutide are not controlled substances and appear nowhere on the list, so they fall OUTSIDE subd. 2(d); for those the duty is the general standard of care rather than this checklist.
Minn. Stat. § 151.37, subd. 2(d)(1)–(6) · verified Sep 2, 2026
WHAT SATISFIES THE EXAMINATION IS BROADER THAN “SEE THE PATIENT TODAY”: it is met where the prescribing practitioner examines the patient at the time the prescription is issued, where “THE PRESCRIBING PRACTITIONER HAS PERFORMED A PRIOR EXAMINATION OF THE PATIENT”, where “ANOTHER PRESCRIBING PRACTITIONER PRACTICING WITHIN THE SAME GROUP OR CLINIC AS THE PRESCRIBING PRACTITIONER HAS EXAMINED THE PATIENT”, or where a consulting practitioner the patient was referred to has examined them. ⚠️ TELEHEALTH ALONE SATISFIES IT FOR ONLY TWO THINGS — ED drugs and medications for opioid use disorder. For every other listed drug the examination must have happened in person, by someone.
Minn. Stat. § 151.37, subd. 2(e) · verified Sep 2, 2026
And the standing-order route survives it: “NOTHING IN PARAGRAPH (d) OR (e) PROHIBITS A LICENSED PRACTITIONER FROM PRESCRIBING A DRUG THROUGH THE USE OF A GUIDELINE OR PROTOCOL PURSUANT TO PARAGRAPH (a).” The protocol authority a med spa relies on is preserved alongside the examination requirement rather than displaced by it.
Minn. Stat. § 151.37, subd. 2(f) · verified Sep 2, 2026
THE ONE EXCEPTION IS NARROW AND NAMED. “Anticipatory compounding” for a practitioner means “THE PREPARATION OF A SUPPLY OF A COMPOUNDED DRUG PRODUCT THAT IS SUFFICIENT TO MEET THE PRACTITIONER’S SHORT-TERM ANTICIPATED NEED for dispensing or administering the drug to PATIENTS TREATED BY THE PRACTITIONER.” ⚠️ AND IT IS NOT A SUPPLY CHANNEL: “ANTICIPATORY COMPOUNDING IS NOT THE PREPARATION OF A COMPOUNDED DRUG PRODUCT FOR WHOLESALE DISTRIBUTION.” Short-term, own patients, never for resale onward.
Minn. Stat. § 151.01, subd. 36 · verified Sep 2, 2026
A practitioner compounding for their own patients does not thereby become a manufacturer: “MANUFACTURING DOES NOT INCLUDE THE PREPACKAGING, EXTEMPORANEOUS COMPOUNDING, OR ANTICIPATORY COMPOUNDING OF A DRUG WITHIN A LICENSED PHARMACY OR BY A PRACTITIONER.” The manufacturer license under § 151.252 is therefore not the gate a compounding med spa runs into — the patient-specific prescription requirement above is.
Minn. Stat. § 151.01, subd. 27 (manufacturing) · verified Sep 2, 2026
⚠️ THE MEDICAL PRACTICE ACT ITSELF IMPOSES NO PRE-TREATMENT EXAMINATION DUTY. Chapter 147 was surveyed in full for this entry: it contains no requirement of a documented history, physical examination, diagnosis or treatment plan before prescribing or administering. Its only use of “physical examination” is the board compelling an examination OF A LICENSEE, and its only use of “good faith” is an immunity provision about prescriptions for released prisoners (§ 147.231). ⚠️ BUT READ IT WITH § 151.37 subd. 2(d): Minnesota puts the examination duty in the DRUG chapter, for a closed list of drug classes rather than for treatment generally.
Minn. Stat. ch. 147 (surveyed in full via the chapter text) · verified Sep 2, 2026
WHAT STANDS IN ITS PLACE: conduct that DEPARTS FROM OR FAILS TO CONFORM TO THE MINIMAL STANDARDS OF ACCEPTABLE AND PREVAILING MEDICAL PRACTICE is a ground for discipline, “IN WHICH CASE PROOF OF ACTUAL INJURY NEED NOT BE ESTABLISHED.” The absence of a written exam rule is therefore not permission — the board can act on the practice pattern alone, with no injured patient.
Minn. Stat. § 147.091, subd. 1(k) · verified Sep 2, 2026
The unethical-conduct ground reaches the same behavior from the other side, and also without injury: conduct LIKELY TO HARM THE PUBLIC, conduct that demonstrates a WILFUL OR CARELESS DISREGARD FOR THE HEALTH, WELFARE, OR SAFETY OF A PATIENT, medical practice that is PROFESSIONALLY INCOMPETENT, and conduct that MAY CREATE UNNECESSARY DANGER to any patient’s life, health, or safety — “in any of which cases, proof of actual injury need not be established.”
Minn. Stat. § 147.091, subd. 1(g) · verified Sep 2, 2026
TELEHEALTH LOWERS NOTHING. A physician-patient relationship MAY be established through telehealth, and a physician providing health care services by telehealth in this state SHALL BE HELD TO THE SAME STANDARDS OF PRACTICE AND CONDUCT as provided for in-person services. Minnesota permits the remote consult and then declines to discount it.
Minn. Stat. § 147.033, subds. 2–3 · verified Sep 2, 2026
How other states answer this
- Alabama
- Alaska
- Arizona
- Arkansas
- California
- Colorado
- Connecticut
- Delaware
- District of Columbia
- Florida
- Georgia
- Hawaii
- Idaho
- Illinois
- Indiana
- Iowa
- Kansas
- Kentucky
- Louisiana
- Maine
- Maryland
- Massachusetts
- Michigan
- Mississippi
- Missouri
- Montana
- Nebraska
- Nevada
- New Hampshire
- New Jersey
- New Mexico
- New York
- North Carolina
- North Dakota
- Ohio
- Oklahoma
- Oregon
- Pennsylvania
- Rhode Island
- South Carolina
- South Dakota
- Tennessee
- Texas
- Utah
- Vermont
- Virginia
- Washington
- West Virginia
- Wisconsin
- Wyoming
Related Minnesota questions
- Is an exam required before a patient can be treated in Minnesota?
- Can the pre-treatment exam be done by telehealth in Minnesota?
Get Minnesota changes as they publish
We scan the Minnesota legislature and licensing boards daily, plus the FDA and the Federal Register. Free weekly Brief — what changed, in plain language, with the source.
Free · unsubscribe in one click · we never sell your address
← All Minnesota rules and changes · MedSpaRadar is regulatory monitoring and reference, not legal, medical, or compliance advice. Verify against the linked primary source and consult qualified counsel before acting — rules change and turn on your specific facts. Legislative data via LegiScan (CC BY 4.0).